{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:31:04Z","timestamp":1786984264400,"version":"build-2736575974"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"33","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,14]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Pulmonary arterial hypertension (PAH) is a severe heart condition, and early diagnosis is crucial for improving patient outcomes. Malondialdehyde (MDA) and superoxide dismutase (SOD) are key oxidative stress (OS) biomarkers potentially crucial to PAH development and progression. This study investigated the potential of serum MDA and SOD as early indicators for PAH detection and assessed their usefulness, along with echocardiographic right ventricular (RV) function (RVF) parameters, in evaluating PAH severity to enhance clinical diagnosis and risk assessment. A group of 73 patients diagnosed with PAH and 54 healthy individuals was recruited. Serum levels of MDA and SOD were assessed, alongside echocardiographic RVF parameters. The Wilcoxon rank-sum test was employed to assess the differences in serum MDA, SOD, and RVF. Spearman rank correlation analysis was conducted to examine the relationship between serum MDA, SOD and RVF. Furthermore, the predictive value of serum MDA and SOD for PAH was evaluated using binary logistic regression model and receiver operating characteristic curve analysis. PAH patients showed significantly elevated MDA levels, decreased SOD activity, and worsened RVF parameters, including reduced RV ejection fraction, RV fractional area change, tricuspid annular plane systolic excursion, peak systolic velocity, and enlarged right atrial, pulmonary trunk, and RV dimensions, compared to healthy group. In both the PAH and healthy groups, serum MDA was inversely related to systolic function indices (RV ejection fraction, RV fractional area change, tricuspid annular plane systolic excursion, peak systolic velocity) but directly related to structural remodeling parameters. In contrast, SOD activity was positively associated with systolic function indices and negatively with structural remodeling. The combined analysis of MDA and SOD demonstrated a sensitivity of 0.875, specificity of 0.753, and an area under the curve of 0.901. The prediction value of PAH was greatest when MDA\u2005&gt;\u20055.315 nmol\/ml and SOD\u2005&lt;\u200550.825\u2009ng\/ml. Patients with PAH show a notable OS imbalance, with elevated MDA levels and reduced SOD activity, closely linked to RV dysfunction and structural remodeling. The elevation of MDA and the reduction of SOD in serum serve as independent risk factors for PAH, and their combined assessment offers significant predictive value for the condition. This study highlights the crucial role of OS in PAH development. A combined approach using biochemical and echocardiographic markers might improve clinical management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050196","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:02:21Z","timestamp":1786730541000},"page":"e50196","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Association between serum oxidative stress-related biomarkers and right ventricular function and their predictive value in PAH"],"prefix":"10.1097","volume":"105","author":[{"given":"Qiaoyun","family":"Wang","sequence":"first","affiliation":[{"name":"Ultrasound Center, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuhuan","family":"Luo","sequence":"additional","affiliation":[{"name":"Ultrasound Department, The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyun","family":"Xiong","sequence":"additional","affiliation":[{"name":"Ultrasound Department, The Second People\u2019s Hospital of Guiyang, Guiyang, Guizhou, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1788-6712","authenticated-orcid":false,"given":"Bei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Ultrasound Center, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260817","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","article-title":"Guidelines for the diagnosis and treatment of pulmonary hypertension: the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the international society of heart and lung transplantation (ISHLT).","volume":"30","author":"Gali\u00e8","year":"2009","journal-title":"Eur Heart J"},{"key":"R2-20260817","doi-asserted-by":"crossref","first-page":"104168","DOI":"10.1016\/j.lpm.2023.104168","article-title":"Pulmonary arterial hypertension.","volume":"52","author":"Boucly","year":"2023","journal-title":"Presse Med"},{"key":"R3-20260817","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S2213-2600(24)00295-9","article-title":"Global, regional, and national burden of pulmonary arterial hypertension, 1990-2021: a systematic analysis for the global burden of disease study 2021.","volume":"13","year":"2025","journal-title":"Lancet Respir Med"},{"key":"R4-20260817","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.3390\/cells9112338","article-title":"Perivascular inflammation in pulmonary arterial hypertension.","volume":"9","author":"Hu","year":"2020","journal-title":"Cells"},{"key":"R5-20260817","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/jama.2022.4402","article-title":"Diagnosis and treatment of pulmonary arterial hypertension: a review.","volume":"327","author":"Ruopp","year":"2022","journal-title":"JAMA"},{"key":"R6-20260817","first-page":"100527","article-title":"Cardiac catheterization in pulmonary arterial hypertension: tips and tricks to enhance diagnosis and guide therapy.","volume":"17","author":"Guglielmi","year":"2024","journal-title":"Int J Cardiol Congenit Heart Dis"},{"key":"R7-20260817","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1080\/02648725.2023.2199234","article-title":"The role of ultrasonic cardiogram in the diagnosis of hypertension complicated with type 2 diabetes mellitus.","volume":"40","author":"Zhou","year":"2024","journal-title":"Biotechnol Genet Eng Rev"},{"key":"R8-20260817","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0068-3","article-title":"MiR-125a-5p ameliorates monocrotaline-induced pulmonary arterial hypertension by targeting the TGF-\u03b21 and IL-6\/STAT3 signaling pathways.","volume":"50","author":"Cai","year":"2018","journal-title":"Exp Mol Med"},{"key":"R9-20260817","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1161\/01.CIR.102.22.2781","article-title":"Primary pulmonary hypertension: a vascular biology and translational research \u201cWork in progress.\u201d.","volume":"102","author":"Archer","year":"2000","journal-title":"Circulation"},{"key":"R10-20260817","doi-asserted-by":"crossref","first-page":"101347","DOI":"10.1016\/j.siny.2022.101347","article-title":"Pulmonary hypertension and oxidative stress: where is the link?","volume":"27","author":"Rawat","year":"2022","journal-title":"Semin Fetal Neonatal Med"},{"key":"R11-20260817","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/CIRCRESAHA.107.158246","article-title":"The NOX on pulmonary hypertension.","volume":"101","author":"Sanders","year":"2007","journal-title":"Circ Res"},{"key":"R12-20260817","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1161\/HYPERTENSIONAHA.114.03261","article-title":"Increased reactive oxygen species, metabolic maladaptation, and autophagy contribute to pulmonary arterial hypertension-induced ventricular hypertrophy and diastolic heart failure.","volume":"64","author":"Rawat","year":"2014","journal-title":"Hypertension"},{"key":"R13-20260817","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1161\/ATVBAHA.113.302107","article-title":"Deficiency of NOX1\/nicotinamide adenine dinucleotide phosphate, reduced form oxidase leads to pulmonary vascular remodeling.","volume":"34","author":"Iwata","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R14-20260817","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1089\/ars.2015.6317","article-title":"Clinical relevance of biomarkers of oxidative stress.","volume":"23","author":"Frijhoff","year":"2015","journal-title":"Antioxid Redox Signal"},{"key":"R15-20260817","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-3-319-63245-2_10","article-title":"Natural antioxidants as potential therapy, and a promising role for melatonin against pulmonary hypertension.","volume":"967","author":"Maarman","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"R16-20260817","doi-asserted-by":"crossref","first-page":"101790","DOI":"10.1016\/j.redox.2020.101790","article-title":"Skin protective and regenerative effects of RM191A, a novel superoxide dismutase mimetic.","volume":"38","author":"Shariev","year":"2021","journal-title":"Redox Biol"},{"key":"R17-20260817","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3390\/toxics10040160","article-title":"Urinary malondialdehyde (MDA) concentrations in the general population-a systematic literature review and meta-analysis.","volume":"10","author":"Toto","year":"2022","journal-title":"Toxics"},{"key":"R18-20260817","doi-asserted-by":"crossref","first-page":"7282","DOI":"10.1080\/10408398.2021.1913400","article-title":"Superoxide dismutase: an updated review on its health benefits and industrial applications.","volume":"62","author":"Islam","year":"2022","journal-title":"Crit Rev Food Sci Nutr"},{"key":"R19-20260817","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1183\/09031936.00072709","article-title":"Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation.","volume":"35","author":"Thenappan","year":"2010","journal-title":"Eur Respir J"},{"key":"R20-20260817","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1161\/CIRCRESAHA.120.316443","article-title":"Epigenetic metabolic reprogramming of right ventricular fibroblasts in pulmonary arterial hypertension: a pyruvate dehydrogenase kinase-dependent shift in mitochondrial metabolism promotes right ventricular fibrosis.","volume":"126","author":"Tian","year":"2020","journal-title":"Circ Res"},{"key":"R21-20260817","first-page":"243","article-title":"Right heart failure in pulmonary hypertension.","volume":"38","author":"Cassady","year":"2020","journal-title":"Cardiol Clin"},{"key":"R22-20260817","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.healun.2024.06.003","article-title":"Right ventricular phenotyping in incident patients with idiopathic pulmonary arterial hypertension.","volume":"43","author":"Ghio","year":"2024","journal-title":"J Heart Lung Transplant"},{"key":"R23-20260817","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.201705-0943OC","article-title":"Features and outcomes of methamphetamine-associated pulmonary arterial hypertension.","volume":"197","author":"Zamanian","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"R24-20260817","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/eurheartj\/eht437","article-title":"Pulmonary hypertension related to congenital heart disease: a call for action.","volume":"35","author":"Dimopoulos","year":"2014","journal-title":"Eur Heart J"},{"key":"R25-20260817","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12890-022-01905-3","article-title":"The zinc transporter ZIP12 regulates monocrotaline-induced proliferation and migration of pulmonary arterial smooth muscle cells via the AKT\/ERK signaling pathways.","volume":"22","author":"Ye","year":"2022","journal-title":"BMC Pulm Med"},{"key":"R26-20260817","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.3390\/molecules27123724","article-title":"Oxidative stress and antioxidative therapy in pulmonary arterial hypertension.","volume":"27","author":"Xu","year":"2022","journal-title":"Molecules"},{"key":"R27-20260817","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.3390\/jcm10153229","article-title":"Echocardiography in pulmonary arterial hypertension: comprehensive evaluation and technical considerations.","volume":"10","author":"Topy\u0142a-Putowska","year":"2021","journal-title":"J Clin Med"},{"key":"R28-20260817","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.hrtlng.2018.01.004","article-title":"Right atrium enlargement predicts clinically significant supraventricular arrhythmia in patients with pulmonary arterial hypertension.","volume":"47","author":"Walig\u00f3ra","year":"2018","journal-title":"Heart Lung"},{"key":"R29-20260817","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.3390\/jpm13121627","article-title":"Novel echocardiographic measurements of right ventricular-pulmonary artery coupling in predicting the prognosis of precapillary pulmonary hypertension.","volume":"13","author":"Topy\u0142a-Putowska","year":"2023","journal-title":"J Pers Med"},{"key":"R30-20260817","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.3390\/jcm15062334","article-title":"Echocardiographic assessment of right ventricular-pulmonary arterial coupling in heart failure: prognostic insights from a systematic review.","volume":"15","author":"Sonaglioni","year":"2026","journal-title":"J Clin Med"},{"key":"R31-20260817","doi-asserted-by":"crossref","first-page":"e012518","DOI":"10.1161\/CIRCHEARTFAILURE.124.012518","article-title":"TAPSE\/sPAP ratio to improve risk assessment in pulmonary arterial hypertension.","volume":"18","author":"Badagliacca","year":"2025","journal-title":"Circ Heart Fail"},{"key":"R32-20260817","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s11906-015-0556-y","article-title":"Biomarkers and prognostic indicators in pulmonary arterial hypertension.","volume":"17","author":"Jardim","year":"2015","journal-title":"Curr Hypertens Rep"},{"key":"R33-20260817","doi-asserted-by":"crossref","first-page":"9385","DOI":"10.3390\/ijms21249385","article-title":"Association of soluble suppression of tumorigenesis-2 (ST2) with endothelial function in patients with ischemic heart failure.","volume":"21","author":"Dimitropoulos","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R34-20260817","doi-asserted-by":"crossref","first-page":"1801887","DOI":"10.1183\/13993003.01887-2018","article-title":"Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives.","volume":"53","author":"Humbert","year":"2019","journal-title":"Eur Respir J"},{"key":"R35-20260817","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.pupt.2017.11.003","article-title":"Baicalein attenuates monocrotaline-induced pulmonary arterial hypertension by inhibiting vascular remodeling in rats.","volume":"48","author":"Shi","year":"2018","journal-title":"Pulm Pharmacol Ther"},{"key":"R36-20260817","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1161\/CIRCULATIONAHA.109.916098","article-title":"Epigenetic attenuation of mitochondrial superoxide dismutase 2 in pulmonary arterial hypertension: a basis for excessive cell proliferation and a new therapeutic target.","volume":"121","author":"Archer","year":"2010","journal-title":"Circulation"},{"key":"R37-20260817","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1161\/HYPERTENSIONAHA.113.02360","article-title":"Oxidative stress is associated with increased pulmonary artery systolic pressure in humans.","volume":"63","author":"Ghasemzadeh","year":"2014","journal-title":"Hypertension"},{"key":"R38-20260817","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/HJH.0b013e328332bcdb","article-title":"Nitric oxide, oxidative stress and inflammation in pulmonary arterial hypertension.","volume":"28","author":"Crosswhite","year":"2010","journal-title":"J Hypertens"},{"key":"R39-20260817","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1089\/ars.2012.4799","article-title":"Superoxide dismutase mimetic, MnTE-2-PyP, attenuates chronic hypoxia-induced pulmonary hypertension, pulmonary vascular remodeling, and activation of the NALP3 inflammasome.","volume":"18","author":"Villegas","year":"2013","journal-title":"Antioxid Redox Signal"},{"key":"R40-20260817","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.hjc.2018.04.003","article-title":"Association between activities of SOD, MDA and Na+-K+-ATPase in peripheral blood of patients with acute myocardial infarction and the complication of varying degrees of arrhythmia.","volume":"60","author":"Yin","year":"2019","journal-title":"Hellenic J Cardiol"},{"key":"R41-20260817","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.echo.2013.02.002","article-title":"Estimation of pulmonary pressures and diagnosis of pulmonary hypertension by Doppler echocardiography: a retrospective comparison of routine echocardiography and invasive hemodynamics.","volume":"26","author":"Lafitte","year":"2013","journal-title":"J Am Soc Echocardiogr"},{"key":"R42-20260817","doi-asserted-by":"crossref","first-page":"100982","DOI":"10.1016\/j.arr.2019.100982","article-title":"Ageing, age-related diseases and oxidative stress: what to do next?","volume":"57","author":"Luo","year":"2020","journal-title":"Ageing Res Rev"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050196","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:01:19Z","timestamp":1786982479000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050196"}},"subtitle":["A single-cohort study."],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":42,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050196","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"assertion":[{"value":"2024-12-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}